Local use of silver compounds in wound infection

Aleksey F. Kharazov , Igor V. Sergienko

For citation:

Abstract

The review discusses the main reasons for the wound infection development, main therapy strategies for topical use for wound damage with a high risk of infection. The mechanisms of the complex action of silver compounds during local use, recommendations on the use of silver compounds in the treatment of burns, chronic wounds of various etiologies are presented, taking into account the phases of the wound process. The results of existing clinical studies devoted to the possibilities of using silver compounds for wound damage are presented. The advantages of silver sulfatiazole as a topical agent with local treatment of wound infections are described.
Key words: wound infection, silver compounds, silver sulfatiazole.

References

1. Young AW, Dewey WS, King BT. Rehabilitation of Burn Injuries: An Update. Phys Med Rehabil Clin N Am 2019;30(1):111-32. DOI: 10.1016/j.pmr.2018.08.004

2. Kuerban D, Maimaiti M, Chen Z. Effects and Safety of Different Silver Preparation in Burns Treatment: A Bayesian Network Meta-analysis. Int J Low Extrem Wounds 2023;22(2):298-306. DOI: 10.1177/15347346211004032

3. Peck MD. Epidemiology of burns throughout the world. Part I: Distribution and risk factors. Burns 2011;37(7):1087-100. DOI: 10.1016/j.burns.2011.06.005

4. Wyrzykowska M. Silver sulfathiazole in the treatment of burn wounds – case report. Leczenie Ran 2022;p.119-22. DOI: 10.5114/lr.2022.122551

5. Адмакин А.Л. Ожоговые рубцы: особенности развития, диагностики и коррекции консервативными методами. Клиническая медицина. 2018;96(1):20-4.

Admakin A.L. Burn scars: features of development, diagnosis and correction with conservative methods. Clinical medicine. 2018;96(1):20-4 (in Russian).

6. Смирнов С.В., Жирикова Е.А., Сычевский М.В. Применение биотехнологий в лечении ожоговых ран: проблемы и перспективы (обзор литературы). Неотложная медицинская помощь. 2011;(1):32-5.

Smirnov S.V., Zhirikova E.A., Sychevsky M.V. The use of biotechnologies in the treatment of burn wounds: problems and prospects (review of literature). Emergency medical care. 2011;(1):32-5 (in Russian).

7. Falcone M, De Angelis B, Pea F et al. Challenges in the management of chronic wound infections. J Glob Antimicrob Resist 2021;(26):140-7. DOI: 10.1016/j.jgar.2021.05.010

8. Образцова А.Е., Ноздреватых А.А. Морфофункциональные особенности репаративного процесса при заживлении кожных ран с учетом возможных рубцовых деформаций (обзор литературы). Вестник новых медицинских технологий. Электронное издание. 2021;15(1). DOI: 10.24412/2075-4094-2021-1-3-3

Obraztsova A.E., Nozdrevatykh A.A. Morphofunctional features of the reparative process during healing of the skin wounds, taking into account possible scar deformations (literature review). Bulletin of new medical technologies. Electronic edition. 2021;15(1). DOI: 10.24412/2075-4094-2021-1-3-3 (in Russian).

9. Saffle JR, Davis B, Williams P. Recent outcomes in the treatment of burn injury in the United States: a report from the American Burn Association Patient Registry. J Burn Care Rehabil 1995;16(3 Pt 1):219-32; discussion 288-9. DOI: 10.1097/00004630-199505000-00002

10. Rowan MP, Cancio LC, Elster EA et al. Burn wound healing and treatment: review and advancements. Crit Care 2015;1(9):243. DOI: 10.1186/s13054-015-0961-2

11. Плешков В.Г., Привольнев В.В., Голуб А.В. Лечение хронических ран. Вестник Смоленской гос. мед. акад. 2015;(2):58-65.

Pleshkov V.G., Zhelnev V.V., Golub A.V. Treatment of chronic wounds. Bulletin of the Smolensk State. Med. Acad. 2015;(2):58-65 (in Russian).

12. Wolcott RD, Hanson JD, Rees EJ et al. Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair Regen 2016;24(1):163-74. DOI: 10.1111/wrr.12370

13. James GA, Swogger E, Wolcott R et al. Biofilms in chronic wounds. Wound Repair Regen 2008;16(1):37-44. DOI: 10.1111/j.1524-475X.2007.00321.x

14. Kalan L, Loesche M, Hodkinson BP et al. Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing. mBio 2016;7(5). DOI: 10.1128/mBio.01058-16

15. Lawall H. Treatment of chronic wounds. Vasa 2012;41(6):396-409. DOI: 10.1024/0301-1526/a000230

16. Agren MS. Wound debridement optimisation. J Wound Care 2014;23(8):381. DOI: 10.12968/jowc.2014.23.8.381

17. Gunasekaran T. Nigusse T, Dhanaraju MD. Silver nanoparticles as real topical bullets for wound healing. J Am Coll Clin Wound Spec 2011;3(4):82-96. DOI: 10.1016/j.jcws.2012.05.001

18. Привольнев В.В., Зубарева Н.А., Каракулина Е.В. Местное лечение раневой инфекции: антисептики или антибиотики? Клиническая микробиология и антимикробная химиотерапия. 2017;(2):131-8.

Privolnev V.V., Zubareva N.A., Karakulina E.V. Local treatment of wound infection: antiseptics or antibiotics? Clinical microbiology and antimicrobial chemotherapy. 2017;(2):131-8 (in Russian).

19. Букина Ю.А., Сергеева Е.А. Антибактериальные свойства и механизм бактерицидного действия наночастиц и ионов серебра. Вестник Казанского технологического университета. 2012;15(14):170-2.

Bukina Yu.A., Sergeeva E.A. Antibacterial properties and the mechanism of the bactericidal effect of nanoparticles and silver ions. Bulletin of Kazan Technological University. 2012;15(14):170-2 (in Russian).

20. Dibrov P, Dzioba J, Gosink KK, Hase CC. Chemiosmotic mechanism of antimicrobial activity of Ag(+) in Vibrio cholerae. Antimicrob Agents Chemother 2002;46(8):2668-70. DOI: 10.1128/AAC.46.8.2668-2670.2002

21. Kim JS, Kuk E, Yu KN et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 2007;3(1):95-101. DOI: 10.1016/j.nano.2006.12.001

22. Morones JR, Elechiguerra JL, Camacho A et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005;16(10):2346-53. DOI: 10.1088/0957-4484/16/10/059

23. Nagy A, Harrison A, Sabbani S et al. Silver nanoparticles embedded in zeolite membranes: release of silver ions and mechanism of antibacterial action. Int J Nanomedicine 2011;(6):1833-52. DOI: 10.2147/IJN.S24019

24. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol Rev 2003;27(2-3):341-53. DOI: 10.1016/S0168-6445(03)00047-0

25. Elliott C. The effects of silver dressings on chronic and burns wound healing. Br J Nurs 2010;19(15):S32-36. DOI: 10.12968/bjon.2010.19.Sup5.77707

26. Kim KJ, Sung WS, Suh BK et al. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 2009;22(2):235-42. DOI: 10.1007/s10534-008-9159-2

27. Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol 2005;52(6):1235-42. DOI: 10.1111/j.1365-2133.2005.06575.x

28. Nadworny PL, Wang J, Tredget EE, Burrell RE. Anti-inflammatory activity of nanocrystalline silver-derived solutions in porcine contact dermatitis. J Inflamm (Lond) 2010;(7):13. DOI: 10.1186/1476-9255-7-13

29. Verdu Soriano J, Rueda Lopez J, Martinez Cuervo F, Soldevilla Agreda J. Effects of an activated charcoal silver dressing on chronic wounds with no clinical signs of infection. J Wound Care 2004;13(10):419,421. DOI: 10.12968/jowc.2004.13.10.26685

30. Munter KC, Beele H, Russell L et al. Effect of a sustained silver-releasing dressing on ulcers with delayed healing: the CONTOP study. J Wound Car 2006;15(5):199-206. DOI: 10.12968/jowc.2006.15.5.26909

31. Jude EB, Apelqvist J, Spraul M, Martini J, Silver Dressing Study G. Prospective randomized controlled study of Hydrofiber dressing containing ionic silver or calcium alginate dressings in non-ischaemic diabetic foot ulcers. Diabet Med 2007;24(3):280-8. DOI: 10.1111/j.1464-5491.2007.02079.x

32. Chuangsuwanich A, Charnsanti O, Lohsiriwat V et al. The efficacy of silver mesh dressing compared with silver sulfadiazine cream for the treatment of pressure ulcers. J Med Assoc Thai 2011;94(5):559-65.

33. Beele H, Meuleneire F, Nahuys M, Percival SL. A prospective randomised open label study to evaluate the potential of a new silver alginate/carboxymethylcellulose antimicrobial wound dressing to promote wound healing. Int Wound J 2010;7(4):262-70. DOI: 10.1111/j.1742-481X.2010.00669.x

34. Jorgensen B, Price P, Andersen KE et al. The silver-releasing foam dressing, Contreet Foam, promotes faster healing of critically colonised venous leg ulcers: a randomised, controlled trial. Int Wound J 2005;2(1):64-73. DOI: 10.1111/j.1742-4801.2005.00084.x

35. Eberlein T, Haemmerle G, Signer M et al. Comparison of PHMB-containing dressing and silver dressings in patients with critically colonised or locally infected wounds. J Wound Care 2012;21(1):12,14-6,18-20. DOI: 10.12968/jowc.2012.21.1.12

36. Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007;33(2):139-48. DOI: 10.1016/j.burns.2006.06.010

37. Fraser JF, Cuttle L, Kempf M, Kimble RM. Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg 2004;74(3):139-42. DOI: 10.1046/j.1445-2197.2004.02916.x

38. Cho Lee AR, Leem H, Lee J, Park KC. Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials 2005;26(22):4670-6. DOI: 10.1016/j.biomaterials.2004.11.041

39. Abe Y, Ueshige M, Takeuchi M et al. Cytotoxicity of antimicrobial tissue conditioners containing silver-zeolite. Int J Prosthodont 2003;16(2):141-4.

40. Атясов И.Н., Атясова М.Л. Местное лечение ожогов серебросодержащими препаратами. Сульфаргин – препарат выбора. Хирургия. 2011;(5):66-8.

Atyasov I.N., Atyasova M.L. Local treatment of burns with silver-containing drugs. Sulfargin is the drug of choice. Surgery. 2011;(5):66-8 (in Russian).

41. Vasile BS, Birca AC, Musat MC, Holban AM. Wound Dressings Coated with Silver Nanoparticles and Essential Oils for The Management of Wound Infections. Materials (Basel) 2020;13(7). DOI: 10.3390/ma13071682

42. Stephen-Haynes J, Toner L. Assessment and management of wound infection: the role of silver. Br J Community Nurs 2007;12(3):S6,S8,S10-12. DOI: 10.12968/bjcn.2007.12.sup1.23045

43. Loo C, Lowery A, Halas N et al. Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett 2005;5(4):709-11. DOI: 10.1021/nl050127s

44. Sumini M, Souza CR, Andrade GJS et al. Cellulose Hydrogel with Hyaluronic Acid and Silver Nanoparticles: Sustained-Release Formulation with Antibacterial Properties against Pseudomonas aeruginosa. Antibiotics (Basel) 2023;12(5). DOI: 10.3390/antibiotics12050873

45. Третьякова Е.И. Комплексное лечение длительно незаживающих ран разной этиологии. Клиническая дерматология и венерология. 2013;11(3):101-6.

Tretyakova E.I. Complex treatment of long-standing non-healing wounds of different etiologies. Clinical dermatology and venereology. 2013;11(3):101-6 (in Russian).

46. Родин А.В., Голуб А.В., Привольнев В.В. Топическое применение сульфатиазола серебра в лечении хронических ран. РМЖ. Медицинское обозрение. 2018;(12):19-23.

Rodin A.V., Golub A.V., Privolnev V.V. Topic use of silver sulfatiazole in the treatment of chronic wounds. RMJ. Medical review. 2018;(12):19-23 (in Russian).

47. Рыбаков А.А. Возможности применения наружных ранозаживляющих средств в хирургической практике. Гастроэнтерология. Хирургия. Интенсивная терапия. Consilium Medicum. 2019;(2):42-7.

Rybakov A.A. The possibilities of applying external wound healing in surgical practice. Gastroenterology. Surgery. Intensive therapy. Consilium Medicum. 2019;(2):42-7 (in Russian).

48. Родин А.В., Привольнев В.В., Барсуков А.Н. Возможности применения сульфатиазола серебра для местного лечения раневой инфекции. Амбулаторная хирургия. 2018;(1-2):42-51.

Rodin A.V., Privolnev V.V., Barsukov A.N. The possibilities of using silver sulfatiazole for local treatment of wound infection. Outpatient surgery. 2018;(1-2):42-51 (in Russian).

49. Блатун Л.А. Местное медикаментозное лечение ран. Хирургия. Журнал им. Н.И. Пирогова. 2011;(4):51-9.

Blatun L.A. Local drug wound treatment. Surgery. N.I. Pirogov Journal. 2011;(4):51-9 (in Russian).

50. Fox CL Jr, Modak SM. Mechanism of silver sulfadiazine action on burn wound infections. Antimicrob Agents Chemother 1974;5(6):582-8. DOI: 10.1128/AAC.5.6.582

51. Самцов А.В., Теличко И.Н., Стаценко А.В., Хайрутдинов В.Р. Применение наружных средств, содержащих соединения серебра, в терапии больных пиодермиями. Вестник дерматологии и венерологии. 2014;(1):75-80.

Samtsov A.V., Telichko I.N., Statsenko A.V., Khairutdinov V.R. The use of external products containing silver compounds in therapy with pyoderma patients. Bulletin of Dermatology and Venerology. 2014;(1):75-80 (in Russian).

52. Бакулев А.Л., Кравченя С.С., Платонова А.Н. Микробная экзема: современные возможности топической терапии с использованием сульфатиазола серебра. Вестник дерматологии и венерологии. 2015;(1):111-21.

Bakulev A.L., Kravchenya S.S., Platonova A.N. Microbial eczema: Modern possibilities of topical therapy using silver sulfatiazole. Bulletin of dermatology and venereology. 2015;(1):111-21 (in Russian).

53. Зиновьев Е.В., Барташевич Е.В., Прохоренко А.В., Жарков А.В. Применение серебросодержащих кремов и раневого покрытия как пути улучшения системы местного лечения ран у пациентов с гнойнонекротическими формами синдрома диабетической стопы. Вестник Новгородского государственного университета. 2010;(59):42-8.

Zinoviev E.V., Bartashevich E.V., Prokhorenko A.V., Zharkov A.V. The use of silver-containing creams and wound coating as a way to improve the system of local treatment of RAS in patients with purobonecrotic forms of diabetic foot syndrome. Bulletin of Novgorod State University. 2010;59:42-8 (in Russian).

54. Каторкин С.Е., Быстров С.А., Безбородов А.И. и др. Применение сульфатиазола серебра в комплексном лечении гнойных ран. РМЖ. 2017;(28):2039-42.

Katorkin S.E., Bystrov S.A., Bezoborodov A.I. et al. The use of silver sulfatiazole in the complex treatment of purulent wounds. RMJ. 2017;(28):2039-42 (in Russian).

55. Привольнев В.В., Забросаев В.С., Даниленков Н.В. Препараты серебра в местном лечении инфицированных ран. Вестник Смоленской государственной медицинской академии. 2015;14(3):85-91.

Privolnev V.V., Zabrosayev V.S., Danilenkov N.V. Silver preparations in local treatment of infected wounds. Bulletin of the Smolensk State Medical Academy. 2015;14(3):85-91 (in Russian).

For citation:Kharazov A.F., Sergienko I.V. Local use of silver compounds in wound infection. Clinical review for general practice. 2024; 5 (11): 142–148 (In Russ.). DOI: 10.47407/kr2024.5.11.00528

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice